INS and endometrial cancer: This included colorectal (46% reduction), pancreatic (59% reduction), liver (53% reduction), gallbladder (65% reduction), kidney (24% reduction), esophageal (40% reduction), ovarian (48% reduction), and endometrial cancers (26% reduction), compared to insulin treatment.16